Post-Marketing Safety Study of Ramucirumab Plus FOLFIRI: Analysis of Age and Initial Dose of Irinotecan in Patients with Metastatic Colorectal Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Post-Marketing Safety Study of Ramucirumab Plus FOLFIRI: Analysis of Age and Initial Dose of Irinotecan in Patients with Metastatic Colorectal Cancer ; day:27 ; month:4 ; year:2023 ; pages:1-9
Drugs - real world outcomes ; (27.4.2023), 1-9
- Urheber
-
Masuishi, Toshiki
Nagaoka, Soshi
Jin, Long
Yoshizawa, Kenichi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40801-023-00366-2
- URN
-
urn:nbn:de:101:1-2023090321015462995724
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Masuishi, Toshiki
- Nagaoka, Soshi
- Jin, Long
- Yoshizawa, Kenichi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
Correction to: Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance
Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity
Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study
Jugular Foramen Syndrome as Initial Presentation of Metastatic Lung Cancer
Inguinal Lymphadenopathy: A Rare Initial Site of Metastatic Lung Carcinoma
Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis
Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase
EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer
Type and dose of radiotherapy used for initial treatment of non-metastatic prostate cancer
Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
Correction to: Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance
Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity
Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study
Jugular Foramen Syndrome as Initial Presentation of Metastatic Lung Cancer
Inguinal Lymphadenopathy: A Rare Initial Site of Metastatic Lung Carcinoma
Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis
Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase
EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer
Type and dose of radiotherapy used for initial treatment of non-metastatic prostate cancer
Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
Correction to: Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance
Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity
Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study
Jugular Foramen Syndrome as Initial Presentation of Metastatic Lung Cancer
Inguinal Lymphadenopathy: A Rare Initial Site of Metastatic Lung Carcinoma
Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis
Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase
EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer